Concepedia

Anand K. Iyer

AK

4

Publications

256

Citations

4

H-Index

2007

Active since

Affiliations

CASI Pharmaceuticals (United States)(Current)

Anand K. Iyer is an author at CASI Pharmaceuticals (United States) specializing in cell proliferation, reactive oxygen species, and oxidative stress.

ORCID

Top concepts

Publications per year

2007–2023

4

Publications

4

Phosphatidylinositol-3-Kinase/Akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen Production

Yongju Lu, Neelam Azad, Liying Wang et al. · American Journal of Respiratory Cell and Molecular Biology · 2009 · 131 citations

, , +19

Tenascin cytotactin epidermal growth factor‐like repeat binds epidermal growth factor receptor with low affinity

Anand K. Iyer, Kien Trân, Christopher W. Borysenko et al. · Journal of Cellular Physiology · 2007 · 66 citations

Integration of a Mobile-Integrated Therapy with Electronic Health Records: Lessons Learned

Malinda Peeples, Anand K. Iyer, Joshua Cohen · Journal of Diabetes Science and Technology · 2013 · 37 citations · Full text

Impact of a Combined Continuous Glucose Monitoring–Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study

Abhimanyu B Kumbara, Anand K. Iyer, Courtney R. Green et al. · JMIR Diabetes · 2023 · 22 citations · Full text

Rows per page

1–4 of 4